Reticulocyte hemoglobin content in 13 critically ill patients: A preliminary study

Transfusion Alternatives in Transfusion Medicine

Volumn 10, Issue 4, 2008, Pages 182-188

  Préfontaine, Geneviève ^a   Darveau, Martin ^b   Ahnadi, Charaf ^c   Lachance, Pierre ^b   Lesur, Olivier ^c   Drouin, Christine ^b   Lamarre, Partice ^c   Vézina, Carmen ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b Hotel Dieu de Levis Hospital   (Canada)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

Anemia; CHr; Critical illness; Inflammation; Iron metabolism

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN; IRON;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BONE MARROW; CLINICAL ARTICLE; CRITICAL ILLNESS; FEMALE; HOSPITALIZATION; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; IRON METABOLISM; MALE; PRIORITY JOURNAL; RETICULOCYTE;

EID: 64349097791     PISSN: 12959022     EISSN: 1778428X     Source Type: Journal    
DOI: 10.1111/j.1778-428X.2009.00123.x     Document Type: Article

References (37)

1. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT Study: Anemia and blood transfusion in the critically ill -current clinical practice in the United States. Crit Care Med 2004; 32: 39-52.
2. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002; 288: 1499-507.
3. Ahsen N, Muller C, Serke S, Frei U, Eckardt KU. Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med 1999; 27: 2630-9.
4. Hobisch-Hagen P, Wiedermann F, Mayr A, et al. Blunted erythropoietic response to anemia in multiply traumatized patients. Crit Care Med 2001; 29: 743-7.
5. Rogiers P, Zhang H, Leeman M, et al. Erythropoietin response is blunted in critically ill patients. Intensive Care Med 1997; 23: 159-62.
6. Rodriguez RM, Corwin HL, Gettinger A, et al. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care 2001; 16: 36-41.
7. Bobbio-Pallavicini F, Verde G, Spriano P, et al. Body iron status in critically ill patients: Significance of serum ferritin. Intensive Care Med 1989; 15: 171-8.
8. Patteril MV, Davey-Quinn AP, Gedney JA, Murdoch SD, Bellamy MC. Functional iron deficiency, infection and systemic inflammatory response syndrome in critical illness. Anaesth Intensive Care 2001; 29: 473-8.
9. Darveau M, Denault AY, Blais N, Notebaert E. Bench-to-bedside review: iron metabolism in critically ill patients. Crit Care 2004; 8: 356-62.
10. Pieracci FM, Barie PS. Diagnosis and management of iron-related anemias in critical illness. Crit Care Med 2006; 34: 1898-905.
11. Munoz M, Romero A, Morales M, et al. Iron metabolism, inflammation and anemia in critically ill patients. A cross-sectional study. Nutr Hosp 2005; 20: 115-20.
12. Means RT Jr. Recent developments in the anemia of chronic disease. Curr Hematol Rep 2003; 2: 116-21.
13. Brugnara C. Iron deficiency and erythropoiesis: New diagnostic approaches. Clin Chem 2003; 49: 1573-8.
14. Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 2002; 48: 1066-76.
15. Thomas C, Wiesner C, Melchior S, Thüroff J. Anaemia in the critically ill patient: Monitoring of erythropoietin therapy. BJU Int 2006; 97: 1161-4.
16. Sears DA. Anemia of chronic disease. Med Clin North Am 1992; 76: 567-79.
17. Harris N, Kunicka J, Kratz A. The ADVIA 2120 hematology system: Flow cytometry-based analysis of blood and body fluids in the routine hematology laboratory. Lab Hematol 2005; 11: 47-61.
18. Mast AE, Blinder MA, Dietzen DJ. Reticulocyte hemoglobin content. Am J Hematol 2008; 83: 307-10.
19. Mast AE, Blinder MA, Lu Q, Flax S, Dietzen DJ. Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency. Blood 2002; 99: 1489-91.
20. Ullrich C, Wu A, Armsby C, et al. Screening healthy infants for iron deficiency using reticulocyte hemoglobin content. JAMA 2005; 294: 924-30.
21. Fishbane S, Shapiro W, Dutka P, Valenzuela OF, Faubert J. A randomized trial of iron deficiency testing strategies in hemodialysis patients. Kidney Int 2001; 60: 2406-11.
22. Chuang CL, Liu RS, Wei YH, Huang TP, Tarng DC. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients. Nephrol Dial Transplant 2003; 18: 370-7.
23. Mittman N, Sreedhara R, Mushnick R, et al. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. Am J Kidney Dis 1997; 30: 912-22.
24. Tsuchiya K, Okano H, Teramura M, et al. Content of reticulocyte hemoglobin is a reliable tool for determining iron deficiency in dialysis patients. Clin Nephrol 2003; 59: 115-23.
25. Hackeng CM, Beerenhout CM, Hermans M, et al. The relationship between reticulocyte hemoglobin content with C-reactive protein and conventional iron parameters in dialysis patients. J Nephrol 2004; 17: 107-11.
26. Mitsuiki K, Harada A, Miyata Y. Reticulocyte hemoglobin content in hemodialysis patients with acute infection. Clin Exp Nephrol 2004; 8: 257-62.
27. LabbéR, Vreman H, Stevenson D. Zinc protoporphyrin: A metabolite with a mission. Clin Chem 1999; 45: 2060-72.
28. Metzgeroth G, Adelberger V, Dorn-Beineke A, et al. Soluble transferrin receptor and zinc protoporphyrin-competitors or efficient partners? Eur J Haematol 2005; 75: 309-17.
29. Baillie F, Morrison A, Fergus I. Soluble transferrin receptor: A discriminating assay for iron deficiency. Clin Lab Haematol 2003; 25: 353-7.
30. LabbéR, Dewanji A. Iron assessment tests: Transferrin receptor vis-à-vis zinc protoporphyrin. Clin Biochem 2004; 37: 165-74.
31. Cook JD, Skikne BS, Baynes RD. Serum transferrin receptor. Annu Rev Med 1993; 44: 63-74.
32. Andrews NC. Forging a field: The golden age of iron biology. Blood 2008; 112: 219-30.
33. Georgopoulos D, Matamis D, Routsi C, et al. Recombinant human erythropoietin therapy in critically ill patients: A dose-response study [ISRCTN48523317]. Crit Care 2005; 9: R508-15.
34. Corwin H, Gettinger A, Pearl R, et al. Efficacy of recombinant human erythropoietin in critically ill patients: A randomized controlled trial. JAMA 2002; 288: 2827-35.
35. Corwin HL, Gettinger A, Rodriguez RM, et al. Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial. Crit Care Med 1999; 27: 2346-50.
36. Walsh TS, Lee RJ, Maciver CR, et al. Anemia during and at discharge from intensive care: The impact of restrictive blood transfusion practice. Intensive Care Med 2006; 32: 100-9.
37. Silver M, Corwin MJ, Bazan A, et al. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: A randomized, double-blind, placebo-controlled trial. Crit Care Med 2006; 34: 2310-16.